Sun Pharma Advanced Research Company Ltd

SPARC Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sun Pharma Advanced Research Company Ltd

₹ 236 -0.72%
03 May 9:29 a.m.
sparc.life BSE: 532872 NSE : SPARC
About

Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products.[1]

Key Points

Leadership[1]
First listed pharma R&D company out of India where founders still own 70% and continue to invest.

Website BSE NSE
  • Market Cap ₹ 7,647 Cr.
  • Current Price ₹ 236
  • High / Low ₹ 474 / 178
  • Stock P/E
  • Book Value ₹ 10.2
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 23.2 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Miscellaneous

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Dec 2023
21 14
113 116
Operating Profit -91 -103
OPM % -432% -740%
8 6
Interest 0 0
Depreciation 3 3
Profit before tax -86 -100
Tax % 0% 0%
-86 -100
EPS in Rs -2.66 -3.07
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Dividend Payout %
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: 4%
5 Years: 7%
3 Years: 12%
1 Year: 21%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Equity Capital
Reserves
Preference Capital
Total Liabilities
CWIP
Investments
Total Assets

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Net Cash Flow

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Shareholding Pattern

Numbers in percentages

4 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
68.46% 68.10% 68.10% 69.09% 69.09% 69.09% 68.23% 65.68% 65.68% 65.68% 65.68% 65.68%
2.61% 2.54% 2.51% 2.38% 2.40% 2.38% 3.48% 3.64% 3.64% 3.67% 3.30% 3.24%
0.02% 0.56% 0.55% 0.76% 0.76% 0.76% 0.76% 0.63% 0.63% 0.65% 0.67% 0.67%
28.91% 28.81% 28.84% 27.77% 27.75% 27.77% 27.53% 30.04% 30.06% 29.99% 30.36% 30.41%
No. of Shareholders 1,10,30194,83495,03992,73694,49493,71896,33798,7771,00,8071,01,4331,03,9901,02,743

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls